Tag: review

  • New mini-review in EVCNA: bacterial extracellular vesicles in WHO priority pathogens

    New mini-review in EVCNA: bacterial extracellular vesicles in WHO priority pathogens

    We’re happy to share our newest publication: “Bacterial extracellular vesicles in priority pathogens: Klebsiella pneumoniae, Staphylococcus aureus, and Streptococcus pneumoniae”, now out in Extracellular Vesicles and Circulating Nucleic Acids as part of the special topic “Extracellular Vesicles: Communication Across Barriers.”

    Antimicrobial resistance (AMR) is one of the biggest threats to global health, and the WHO’s 2024 Bacterial Priority Pathogens List tells us where research is needed the most. In this mini-review, we bring together what is currently known about the vesicles released by three of these pathogens: carbapenem-resistant K. pneumoniae, methicillin-resistant S. aureus, and macrolide-resistant S. pneumoniae. We look at how vesicles can carry resistance-associated proteins, help transfer resistance genes, shape inflammation and immune responses, and how they are being explored as vaccine platforms. We also point out where the gaps are. For example, vesicles from macrolide-resistant pneumococci are still largely unexplored, and standardized isolation methods are needed so studies can be compared.

    This paper is Miriana’s work, and she was the driving force behind it. She carried the project, and she did it while managing lab work, student supervision, and a lot of careful time management. Miriana handled every round with patience and drive. Congratulations Miriana, and thank you!

    We hope this overview is a useful starting point for anyone working on AMR, bacterial vesicles, or vaccine development.

    📄 Read the article (open access): https://doi.org/10.20517/evcna.2026.129

  • New perspective in Trillium Extracellular Vesicles 2026: bacterial EVs, between biotech promise and biological “black boxes”

    New perspective in Trillium Extracellular Vesicles 2026: bacterial EVs, between biotech promise and biological “black boxes”

    I’m happy to share that my perspective article, “Bacterial extracellular vesicles: From biotechnological tools to biological ‘black boxes’”, is now out in the 2026 issue of Trillium Extracellular Vesicles.

    What the article is about
    Bacterial EVs (bEVs) are being fast developed as drug-delivery vehicles, vaccine platforms (the OMV-based meningococcal vaccines are the best-known example) and diagnostic tools. Our understanding of their basic biology hasn’t kept up. We still don’t know how vesicles form, how cargo is selected, or why vesicle populations are so heterogeneous, especially in Gram-positive bacteria, where vesicles have to cross a thick cell wall. Differences in isolation methods and the lack of standardised markers also make studies hard to compare. This piece argues that resolving these mechanisms is essential for both fundamental microbiology and the medical potential of bEVs.

    📄 Read the article: DOI 10.47184/tev.2026.01.03
    📚 Browse the full issue: Trillium Extracellular Vesicles 2026

    Full text requires a free MyTrillium account.